Sangamo Therapeutics

Sangamo Therapeutics

Focus:

Type: Public Corporation
Founded: 1995


Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

Leadership
Jeffrey Marrazzo
Founder


Financial Performance



News